OOIR: Observatory of International Research

Papers

(The TQCC of Lung is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It?	336
ACE2: The Major Cell Entry Receptor for SARS-CoV-2	285
Update 2020: Management of Non-Small Cell Lung Cancer	247
Evaluation and Management of Children with Obstructive Sleep Apnea Syndrome	87
Evaluation and Management of Adults with Obstructive Sleep Apnea Syndrome	62
Are Serum Interleukin 6 and Surfactant Protein D Levels Associated with the Clinical Course of COVID-19?	56
Robotic-Assisted Navigation Bronchoscopy as a Paradigm Shift in Peripheral Lung Access	55
Blood Cell Count Derived Inflammation Indexes in Patients with Idiopathic Pulmonary Fibrosis	53
Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study	52
Connective Tissue Disease-Related Interstitial Lung Disease: Prevalence, Patterns, Predictors, Prognosis, and Treatment	39
Update 2021: Management of Small Cell Lung Cancer	38
Pulmonary Complications of Cardiac Surgery	34
Guidelines for the Treatment of Pulmonary Arterial Hypertension	33
COVID-19 in Children with Asthma	31
P2X3-Receptor Antagonists as Potential Antitussives: Summary of Current Clinical Trials in Chronic Cough	30
The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer	27
Tofacitinib as a Steroid-Sparing Therapy in Pulmonary Sarcoidosis, an Open-Label Prospective Proof-of-Concept Study	26
Moderate or Severe Impairment in Pulmonary Function is Associated with Mortality in Sarcoidosis Patients Infected with SARS‑CoV‑2	24
Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant	24
Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy	24
Novel Robotic-Assisted Cryobiopsy for Peripheral Pulmonary Lesions	23
Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials	22
Fibrotic Hypersensitivity Pneumonitis: Diagnosis and Management	22
Is There (Will There Be) a Post-COVID-19 Chronic Cough?	21
Prevalence and Outcome of Acute Respiratory Distress Syndrome in Traumatic Brain Injury: A Systematic Review and Meta-Analysis	20

Cancer, Phase Angle and Sarcopenia: The Role of Diet in Connection with Lung Cancer Prognosis	20
Advances in Targeted Therapy for Progressive Fibrosing Interstitial Lung Disease	19
Strongyloides stercoralis	19
Prevalence and Mortality of Pulmonary Hypertension in ESRD: A Systematic Review and Meta-analysis	19
A Randomized, Controlled, Pilot Study of CPAP for Patients with Chronic Cough and Obstructive Sleep Apnea	19
Uniportal Versus Multiportal Video-Assisted Thoracoscopic Lobectomy for Lung Cancer: An Updated Meta-analysis	17
Prognostic Value of Geriatric Nutritional Risk Index for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis	17
Association Between Serum S100A8/S100A9 Heterodimer and Pulmonary Function in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease	17
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough	17
The Utility of Diaphragm Ultrasound in Reducing Time to Extubation	17
Long-Term Treatment Outcomes after Behavioral Speech Therapy for Chronic Refractory Cough	16
Use of Thiols in the Treatment of COVID-19: Current Evidence	15
Diffuse Alveolar Hemorrhage in Cardiac Diseases	15
What is the Role of Over 100 Excipients in Over the Counter (OTC) Cough Medicines?	14
Urinary Metals, Arsenic, and Polycyclic Aromatic Hydrocarbon Exposure and Risk of Self-reported Emphysema in the US Adult Population	14
Forced Vital Capacity and Low Frequency Reactance Area Measurements Are Associated with Asthma Control and Exacerbations	14
Follow-Up Functional Class and 6-Minute Walk Distance Identify Long-Term Survival in Pulmonary Arterial Hypertension	14
Prevalence and Severity Distribution of Type 2 Inflammation-Related Comorbidities Among Patients with Asthma, Chronic Rhinosinusitis with Nasal Polyps, and Atopic Dermatitis	13
Impact of Biologic Therapy on the Small Airways Asthma Phenotype	13
Twenty-Year Reflection on the Impact of World Trade Center Exposure on Pulmonary Outcomes in Fire Department of the City of New York (FDNY) Rescue and Recovery Workers	13
Shape-Sensing Robotic-Assisted Bronchoscopy with Concurrent use of Radial Endobronchial Ultrasound and Cone Beam Computed Tomography in the Evaluation of Pulmonary Lesions	13
Imaging of Chronic Thromboembolic Disease	13
Infectious Complications in Lung Transplant Recipients	12
Noninvasive Measurement of Pulmonary Function in Experimental Mouse Models of Airway Disease	12
Quantitative CT Evidence of Airway Inflammation in WTC Workers and Volunteers with Low FVC Spirometric Pattern	12
Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study	12
Can a New Scoring System Improve Prediction of Pulmonary Hypertension in Newly Recognised Interstitial Lung Diseases?	12
Cone Beam CT Guidance Improves Transbronchial Lung Cryobiopsy Safety	12
Prevalence and Severity of Dysphagia Using Videofluoroscopic Swallowing Study in Patients with Aspiration Pneumonia	12
Objective Assessment of Cough: An Early Marker of Response to Biological Therapies in Asthma?	12
Chronic Hepatitis C Virus Infection is Associated with an Increased Risk of Lung Cancer: A Systematic Review and Meta-analysis	11
Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis	11
Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia	11
Radiologic Characteristics of Non-tuberculous Mycobacteria Infection in Patients with Bronchiectasis	10
Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study	10
ETS1 Ameliorates Hyperoxia-Induced Alveolar Epithelial Cell Injury by Regulating the TGM2-Mediated Wnt/β-Catenin Pathway	10
Increased Th17 and Th22 Cell Percentages Predict Acute Lung Injury in Patients with Sepsis	10
Proposed Pathogenesis of Diffuse Alveolar Hemorrhage in Idiopathic Pulmonary Hemosiderosis	9
Impact of High-Grade Patterns in Early-Stage Lung Adenocarcinoma: A Multicentric Analysis	9
The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic Cough	9
Vaping Associated Pulmonary Nontuberculous Mycobacteria	9
Narrative Review of the Mechanisms and Treatment of Cough in Asthma, Cough Variant Asthma, and Non-asthmatic Eosinophilic Bronchitis	9
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction	9
Chronic Thromboembolic Pulmonary Hypertension	8
A Multidisciplinary Lung Cancer Program: Does It Reduce Delay Between Diagnosis and Treatment?	8
Pulmonary Embolism in Acute Asthma Exacerbation: Clinical Characteristics, Prediction Model and Hospital Outcomes	8
Management of Chronic Cough in Adult Primary Care: A Qualitative Study	8
EUS-B-FNA Enhances the Diagnostic Yield of EBUS Bronchoscope for Intrathoracic Lesions	8
Progranulin and Activin A Concentrations are Elevated in Serum from Patients with Acute Exacerbations of Idiopathic Pulmonary Fibrosis	8
Genomic Analysis Reveals the Prognostic and Immunotherapeutic Response Characteristics of Ferroptosis in Lung Squamous Cell Carcinoma	8

Quantitative Pectoralis Muscle Area is Associated with the Development of Lung Cancer in a Large Lung Cancer Screening Cohort	8
Age-Dependent Progression in Lung Pathophysiology can be Prevented by Restoring Fatty Acid and Ceramide Imbalance in Cystic Fibrosis	8
Validation and Meaningful Change Thresholds for an Objective Cough Frequency Measurement in Chronic Cough	8
The Role of Galectins in Chronic Lung Allograft Dysfunction	8
Obstructive Sleep Apnea Severity, Body Mass Index, and Circulating Levels of Cellular Adhesion Molecules	8
Incidence and Risk of Pneumococcal Pneumonia in Adults with Distinct Underlying Medical Conditions: A Population-Based Study	7
Stage I and II Small-Cell Lung Cancer—New Challenge for Surgery	7
The Relationship Between Cough Reflex Sensitivity and Exacerbation Frequency in Chronic Obstructive Pulmonary Disease	7
Gut–lung Microbiota Interactions in Chronic Obstructive Pulmonary Disease (COPD): Potential Mechanisms Driving Progression to COPD and Epidemiological Data	7
Left Upper Lobectomy for Lung Cancer as a Risk Factor for Cerebral Infarction: A Systematic Review and Meta-Analysis	7
Cough in the Elderly During the COVID-19 Pandemic	7
On Chronic Cough Diagnosis, Classification, and Treatment	7
Inhalational Constrictive Bronchiolitis: The Evolution of our Understanding of this Disease	7
Risk Factors, Prognosis, and a New Nomogram for Predicting Cancer-Specific Survival Among Lung Cancer Patients with Brain Metastasis: A Retrospective Study Based on SEER	7
Association of Xpert MTB/RIF Cycle Threshold Values with Tuberculosis Treatment Outcomes	7
Alveolar Epithelial Type 2 Cell Dysfunction in Idiopathic Pulmonary Fibrosis	7
Cough Presentation and Cough-Related Healthcare Utilization in Tertiary Care: Analysis of Routinely Collected Academic Institutional Database	7
Pulmonary Pathology Diagnoses in the US Military During the Global War on Terrorism	7
Nationwide Real-Life Safety and Treatment Exposure Data on Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III, Locally Advanced, Non-small Cell Lung Cancer: Analysis of Patients E	7
Pulmonary Arteriovenous Malformations in Non-hereditary Hemorrhagic Telangiectasia Patients: An 18-Year Retrospective Study	7
Obesity Predicts Treatment Response to Proton Pump Inhibitor Therapy in Patients with Chronic Cough	7